Cognition Therapeutics Files 8-K on Financials
Ticker: CGTX · Form: 8-K · Filed: May 7, 2025 · CIK: 1455365
| Field | Detail |
|---|---|
| Company | Cognition Therapeutics INC (CGTX) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
TL;DR
Cognition Therapeutics dropped an 8-K detailing its financial condition and results. Check it out.
AI Summary
Cognition Therapeutics, Inc. filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31).
Why It Matters
This 8-K filing provides an update on Cognition Therapeutics' financial status and operational results, which is crucial information for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any new or significant risks.
Key Numbers
- 001-40886 — Commission File Number (Identifies the company's SEC filing record.)
- 13-4365359 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Cognition Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- May 7, 2025 (date) — Date of earliest event reported
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these results are not provided in the excerpt.
When was Cognition Therapeutics, Inc. incorporated?
The filing states the company's state of incorporation is Delaware.
What is the principal executive office address for Cognition Therapeutics, Inc.?
The principal executive offices are located at 2500 Westchester Avenue, Purchase, NY 10577.
What is the SIC code for Cognition Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code is 2836, for BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What is the fiscal year end for Cognition Therapeutics, Inc.?
The fiscal year end for the company is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding COGNITION THERAPEUTICS INC (CGTX).